AphioTx is excited to announce we have been chosen to advance to the top 10 at Start Up TNT’s Life Sciences Investment Summit. Watch the recording of our pitch that landed us the next spot in the summit.
Over a 15-year period, key scientific discoveries were made that changed our understanding of the important roles pannexin-1 channels play in opioid withdrawal, chronic pain, stroke, and cognitive impairment. These discoveries were led by three researchers from the Hotchkiss Brain Institute at the University of Calgary: Drs. Tuan Trang, Roger Thompson, and Darren Derksen.
Researchers out of the Hotchkiss Brain Institute at the University of Calgary have discovered a treatment that shows potential in alleviating opioid withdrawal symptoms, which can help break the cycle of opioid use for millions worldwide. Join our leading scientist Dr. Tuan Trang and other scientific, medical and mental health and addictions experts for this community-run webinar with the Hotchkiss Brain Institute discussing the potential of this research, what this means for communities worldwide, and plans to fuel the development of the science from bench to bedside.
Calgary-based Company Launches with Potential Innovative Treatment to Help Tackle Global Opioid Crisis
AphioTx, a clinical research company from the University of Calgary developing a potential treatment for opioid withdrawal, is pleased to announce its formal launch today.
The CIHR Project Grant program chose projects led by Drs. Sabine Gilch, PhD, Tuan Trang, PhD, and Patrick Whelan, PhD, all researchers in the University of Calgary Faculty of Veterinary Medicine (UCVM).